Clinical Trial Update: Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis [NA]

View source ↗

Summary

A randomized trial evaluated albendazole in patients with epilepsy due to neurocysticercosis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Neurocysticercosis

Drugs mentioned

• Albendazole (ALBENDAZOLE)

Snippet

Sponsor: Johns Hopkins University | Conditions: Epilepsy, Cysticercosis | NA | Status: COMPLETED